Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)


This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

Analysis of Revenues

Microsoft Excel

Paying users area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Revenues as Reported

Allergan Inc., income statement, revenues

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Eye Care Pharmaceuticals
Skin Care and Other
Specialty Pharmaceuticals
Breast Aesthetics
Obesity Intervention
Facial Aesthetics
Core Medical Devices
Medical Devices
Product net sales

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

Item Description The company
Product net sales Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Allergan Inc. product net sales increased from 2012 to 2013 and from 2013 to 2014.